The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials," said Juan Pablo Fras, M.D., Medical Director, Mounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in The approval was based on results from the phase 3 SURPASS program, which included active comparators of injectable semaglutide 1 mg, insulin glargine and insulin degludec
Sun Pharma gets DCGI nod to make generic semaglutide for weight management Noveltreat will launch after semaglutide patent expiry in India Drug approved after Phase III trial and will be available in five dose strengths Did our AI summary help
Individual medical conditions and prescribed nutrition plans still require professional guidance
If it seems impossible to lose weight, no matter what you do, no matter what you change, no matter how hard you try, then it is a good time to try a GLP- 1 Antagonist drug